Affinity DataKi: 1.30nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 3.5nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 4.10nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 4.60nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 6.90nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 7.40nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 9.70nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 9.70nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 22nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 36nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 66nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 79nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 82nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 93nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 110nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 140nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 290nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 330nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 690nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptide (unknown origin)More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
University Of Tennessee Health Science Center
Curated by ChEMBL
University Of Tennessee Health Science Center
Curated by ChEMBL
Affinity DataKi: 800nMAssay Description:Inhibition of recombinant ATX mediated hydrolysis of FS-3More data for this Ligand-Target Pair
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
University Of Tennessee Health Science Center
Curated by ChEMBL
University Of Tennessee Health Science Center
Curated by ChEMBL
Affinity DataKi: 1.60E+3nMAssay Description:Inhibition of recombinant ATX mediated hydrolysis of FS-3More data for this Ligand-Target Pair
Affinity DataKi: 8.70E+3nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1A domain peptide (unknown origin)More data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
Affinity DataIC50: 6nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of human recombinant GSK3-beta after 1 hr by KinaseGlo luciferase assayMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair